Literature DB >> 12093673

Catalase, a specific antigen in the feces of human subjects infected with Helicobacter pylori.

Nobuyuki Suzuki1, Masahiko Wakasugi, Seigo Nakaya, Naomi Kokubo, Masami Sato, Hirofumi Kajiyama, Ryoki Takahashi, Haruhisa Hirata, Yohji Ezure, Yoshihiro Fukuda, Takashi Shimoyama.   

Abstract

Recently, we reported the production of three new monoclonal antibodies with high specificity for a Helicobacter pylori antigen suitable for diagnosis of H. pylori infection. The aim of the present study was to identify the antigen recognized by these monoclonal antibodies concerning both H. pylori and the feces of human subjects infected with H. pylori. The cellular antigen was purified from an H. pylori cell extract by immunoaffinity column chromatography with the monoclonal antibody as a ligand. The amino-terminal amino acid sequences (eight residues) of the purified antigen and H. pylori catalase were the same. The molecular weights of native and subunit, specific catalase activity, and UV and visible spectra of the purified antigen were in good agreement with those of H. pylori catalase. The human fecal antigens were purified from two fecal samples of two H. pylori-positive subjects by ammonium sulfate precipitation, CM-Sephadex C(50) chromatography, and the same immunoaffinity chromatography used for the H. pylori cellular antigen. The fecal antigens had catalase activity. The amino-terminal amino acid sequences (five residues) of the human fecal antigen and H. pylori catalase were the same. The monoclonal antibodies reacted with the native cellular antigen, but did not react with the denatured antigen, human catalase, and bovine catalase. The results show that the target antigen of the monoclonal antibodies is native H. pylori catalase and that the monoclonal antibodies are able to specifically detect the antigen, which exists in an intact form, retaining the catalase activity in human feces.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093673      PMCID: PMC120039          DOI: 10.1128/cdli.9.4.784-788.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  20 in total

1.  Stool immunoassay for Helicobacter pylori is not specific enough.

Authors:  M Guslandi
Journal:  BMJ       Date:  2000-06-03

2.  Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity.

Authors:  N Ramarao; S D Gray-Owen; T F Meyer
Journal:  Mol Microbiol       Date:  2000-10       Impact factor: 3.501

3.  Catalase negative mutants of Helicobacter pylori.

Authors:  T U Westblom; S Phadnis; W Langenberg; K Yoneda; E Madan; B R Midkiff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

4.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.

Authors:  R F BEERS; I W SIZER
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Helicobacter pylori catalase.

Authors:  S L Hazell; D J Evans; D Y Graham
Journal:  J Gen Microbiol       Date:  1991-01

7.  Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy.

Authors:  A Makristathis; W Barousch; E Pasching; C Binder; C Kuderna; P Apfalter; M L Rotter; A M Hirschl
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen.

Authors:  Nobuyuki Suzuki; Masahiko Wakasugi; Seigo Nakaya; Keiko Okada; Ritsuko Mochida; Masami Sato; Hirofumi Kajiyama; Ryoki Takahashi; Haruhisa Hirata; Yohji Ezure; Yasuhiro Koga; Yoshihiro Fukuda; Takashi Shimoyama
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

9.  Cloning and genetic characterization of Helicobacter pylori catalase and construction of a catalase-deficient mutant strain.

Authors:  S Odenbreit; B Wieland; R Haas
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

Review 10.  The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

Authors:  J H Walsh; W L Peterson
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

View more
  4 in total

1.  Use of a novel enzyme immunoassay based on detection of circulating antigen in serum for diagnosis of Helicobacter pylori infection.

Authors:  Abdelfattah M Attallah; Hisham Ismail; Gellan G Ibrahim; Mohamed Abdel-Raouf; Ahmed M El-Waseef; Mohamed Abdel-Wahab
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection.

Authors:  Tadashi Shimoyama; Manabu Sawaya; Atsushi Ishiguro; Norihiro Hanabata; Tetsuro Yoshimura; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2011-01-25       Impact factor: 7.527

3.  Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Yoshihiro Fukuda; Tadashi Shimoyama; Masumi Okuda; Chieko Kato; Intetsu Kobayashi; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

4.  Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy.

Authors:  Ryuzo Deguchi; Masashi Matsushima; Takayoshi Suzuki; Tetsuya Mine; Ryuki Fukuda; Makoto Nishina; Hideki Ozawa; Atsushi Takagi
Journal:  J Gastroenterol       Date:  2009-05-21       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.